{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:18:37Z","timestamp":1760548717186},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,7,19]],"date-time":"2008-07-19T00:00:00Z","timestamp":1216425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Soc Psychiat Epidemiol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s00127-008-0415-0","type":"journal-article","created":{"date-parts":[[2008,7,19]],"date-time":"2008-07-19T05:04:40Z","timestamp":1216443880000},"page":"143-150","source":"Crossref","is-referenced-by-count":10,"title":["Outcome study of first-episode schizophrenia in a developing country: quality of life and antipsychotics"],"prefix":"10.1007","volume":"44","author":[{"given":"Kok Yoon","family":"Chee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,19]]},"reference":[{"key":"415_CR1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1192\/bjp.174.5.399","volume":"174","author":"S Amin","year":"1999","unstructured":"Amin S et al (1999) Evaluating the health of the nation outcome scales: reliability and validity in a three-year follow-up of first-onset psychosis. Br J Psychiatry 174:399\u2013403","journal-title":"Br J Psychiatry"},{"key":"415_CR2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"T Barnes","year":"1989","unstructured":"Barnes T (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672\u2013676","journal-title":"Br J Psychiatry"},{"key":"415_CR3","doi-asserted-by":"crossref","unstructured":"Bradford LD (2005) The ethnopharmacology of atypical antipsychotics, CNS Spectr 10 (2005) (3 Suppl. 2):S6\u2013S12","DOI":"10.1017\/S1092852900026559"},{"key":"415_CR4","unstructured":"Chan CH et al (1997) Hong Kong Chinese Version WHOQOL-108 and its BREF form. In: Quality of life symposium. Hong Kong Polytechnic University, Hong Kong"},{"issue":"4","key":"415_CR5","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1016\/S0924-977X(03)92022-0","volume":"13","author":"HR Chaudhry","year":"2003","unstructured":"Chaudhry HR, Kongsakon R et al (2003) Quality of life and clinical outcomes for Asian outpatients with schizophrenia: a double-blind randomized comparison of olanzapine and haloperidol. J Eur College Neuropsychopharm 13(4):S309","journal-title":"J Eur College Neuropsychopharm"},{"key":"415_CR6","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences. 2nd, Lawrence Earlbaum Associates, Hillsdale","edition":"2"},{"key":"415_CR7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","volume":"321","author":"J Geddes","year":"2000","unstructured":"Geddes J et al (2000) Atypical antipsychotics in the treatment of schizophrenia: systemic overview and meta-regression analysis. BMJ 321:1371\u20131376","journal-title":"BMJ"},{"key":"415_CR8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1192\/bjp.147.3.283","volume":"147","author":"J Gerlach","year":"1985","unstructured":"Gerlach J, Behnke K, Heltberg J, Munk-Anderson E, Nielsen H (1985) Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations. Br J Psychiatry 147:283\u2013288","journal-title":"Br J Psychiatry"},{"key":"415_CR9","first-page":"79","volume":"58","author":"CI Hasanah","year":"2003","unstructured":"Hasanah CI et al (2003) World Health Organization Quality of Life Assessment; Brief Version in Bahasa Malaysia. Malaysia Med J 58:79\u201388","journal-title":"Malaysia Med J"},{"issue":"s311","key":"415_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0447.1984.tb06856.x","volume":"69","author":"C H\u00e4rnryd","year":"1984","unstructured":"H\u00e4rnryd C, Bjerkenstedt L, Bj\u00f6rk K et al (1984) Clinical evaluation of sulpiride in schizophrenic patients\u2014a double-blind comparison with chlorpromazine. Sulpiride in schizophrenic. Acta Psychiatr Scand 69(s311):7\u201330","journal-title":"Acta Psychiatr Scand"},{"key":"415_CR11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","volume":"63","author":"PB Jones","year":"2006","unstructured":"Jones PB et al (2006) Randomized controlled trial of the effect on quality of life of second- vs. first- generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry 63:1079\u20131087","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"415_CR12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0920-9964(00)90428-6","volume":"41","author":"A Kulkarni","year":"2000","unstructured":"Kulkarni A, Adams A, Corteling N et al (2000) Sex differences in the quality of life of people with schizophrenia. Schizophr Res 41(1):58\u201359","journal-title":"Schizophr Res"},{"key":"415_CR13","volume-title":"Cultural relevancy of WHOQOL structure in Hong Kong Chinese. Quality of Life Symposium","author":"KF Leung","year":"1997","unstructured":"Leung KF et al (1997) Cultural relevancy of WHOQOL structure in Hong Kong Chinese. Quality of Life Symposium. Hong Kong Polytechnic University, Hong Kong"},{"key":"415_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.0065-1591.2000.0ap25.x","volume":"101","author":"A Leung","year":"2000","unstructured":"Leung A, Chua P (2000) Sex differences in schizophrenia,a review of the literature. Acta Psychiatr Scand 101:3\u201338","journal-title":"Acta Psychiatr Scand"},{"key":"415_CR15","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1176\/appi.ajp.160.8.1396","volume":"160","author":"JA Lieberman","year":"2003","unstructured":"Lieberman JA et al (2003) Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry 160:1396\u20131404","journal-title":"Am J Psychiatry"},{"issue":"12","key":"415_CR16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Eng J Med 353(12):1209\u20131223","journal-title":"N Eng J Med"},{"key":"415_CR17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/ajp.140.4.490","volume":"140","author":"KM Lin","year":"1983","unstructured":"Lin KM, Finder E (1983) Neuroleptic dosage for Asians. Am J Psychiatry 140:490\u2013491","journal-title":"Am J Psychiatry"},{"issue":"10","key":"415_CR18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1176\/ajp.146.10.1307","volume":"146","author":"KM Lin","year":"1989","unstructured":"Lin KM, Poland RE, Nuccio I (1989) A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients. Am J Psychiatry 146(10):1307\u20131311","journal-title":"Am J Psychiatry"},{"key":"415_CR19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1192\/bjp.bp.105.020982","volume":"191","author":"S Marwaha","year":"2007","unstructured":"Marwaha S, Johnson S, Bebbington P et al (2007) Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br J Psychiatry 191:30\u201337","journal-title":"Br J Psychiatry"},{"key":"415_CR20","volume-title":"Malaysian burden of disease and injury study: health prioritization: burden of disease approach","author":"Ministry Of Health","year":"2004","unstructured":"Ministry Of Health (2004) Malaysian burden of disease and injury study: health prioritization: burden of disease approach. Division of Burden of Disease, Institute of Public Health: Ministry of Health, Malaysia"},{"key":"415_CR21","doi-asserted-by":"crossref","unstructured":"Mubarak AR (2005) Social functioning and quality of life of people with schizophrenia in the northern region of Malaysia. Australian e-Journal for the Advancement of the Mental Health 4(3)","DOI":"10.5172\/jamh.4.3.200"},{"key":"415_CR22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1037\/1040-3590.9.3.196","volume":"9","author":"KT Mueser","year":"1997","unstructured":"Mueser KT, McHugo GJ, Curran PJ (1997) Factor structure of the brief psychiatric rating scale in schizophrenia. Psychol Assess 9:196\u2013204","journal-title":"Psychol Assess"},{"key":"415_CR23","unstructured":"National Economy Planning Unit (2005) Selangor"},{"key":"415_CR24","volume-title":"National Mental Health Registry\u2019s: Report 2003\u20132004","author":"National Mental Health Registry","year":"2005","unstructured":"National Mental Health Registry (2005) National Mental Health Registry\u2019s: Report 2003\u20132004. Ministry of Health, Malaysia"},{"key":"415_CR25","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.290.20.2693","volume":"290","author":"R Rosenheck","year":"2003","unstructured":"Rosenheck R et al (2003) Effectiveness and cost of olanzapine and haloperidol in treatment of schizophrenia: a randomized controlled trial. JAMA 290:2693\u20132702","journal-title":"JAMA"},{"issue":"3","key":"415_CR26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1176\/appi.ajp.163.3.411","volume":"163","author":"R Rosenheck","year":"2006","unstructured":"Rosenheck R, Leslie D, Keefe R et al (2006) Barriers to employment for people with Schizophrenia. Am J Psychiatry 163(3):411\u2013417","journal-title":"Am J Psychiatry"},{"key":"415_CR27","unstructured":"Rummel C et al. (2006) New generation antipsychotics for first episode schizophrenia. Cochrane Database Syst. Rev. 4th Quarter"},{"key":"415_CR28","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.pmed.0020141","volume":"2","author":"S Saha","year":"2005","unstructured":"Saha S, Chant D, Welham J, McGrath J (2005) A systematic review of the prevalence of schizophrenia. PLoS Med 2:e141","journal-title":"PLoS Med"},{"key":"415_CR29","unstructured":"Sameerah SAR, Sarojini S (eds) (2007) Malaysian Statistics on Medicine 2005, Kuala Lumpur"},{"key":"415_CR30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.162.5.947","volume":"162","author":"N Schooler","year":"2005","unstructured":"Schooler N et al (2005) Risperidone and haloperidol in first-episode psychosis: a long term randomized trial. Am J Psychiatry 162:947\u2013953","journal-title":"Am J Psychiatry"},{"key":"415_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"G Simpson","year":"1970","unstructured":"Simpson G, Angus J (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212:11\u201319","journal-title":"Acta Psychiatr Scand"},{"key":"415_CR32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","volume":"13","author":"SM Skevington","year":"2004","unstructured":"Skevington SM, Lotfy M, O\u2019Connell KA (2004) The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A Report from the WHOQOL Group. Qual Life Res 13:299\u2013310","journal-title":"Qual Life Res"},{"key":"415_CR33","doi-asserted-by":"crossref","unstructured":"Soares BGO, Fenton M, Chue P (2008) Sulpiride for schizophrenia. Cochrane Schizophrenia Group Cochrane Database of Systematic Reviews, 2","DOI":"10.1002\/14651858.CD001944.pub2"},{"issue":"1","key":"415_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","volume":"29","author":"TS Stroup","year":"2003","unstructured":"Stroup TS et al (2003) The national institute of mental health clinical antipsychotic trials of intervention effectiveness (CATIE) project. Schizophr Bull 29(1):15\u201331","journal-title":"Schizophr Bull"},{"key":"415_CR35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/ajp.2007.164.3.428","volume":"164","author":"MS Swartz","year":"2007","unstructured":"Swartz MS et al (2007) Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. Am J Psychiatry 164:428\u2013430","journal-title":"Am J Psychiatry"},{"key":"415_CR36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"The WHOQOL Group","year":"1998","unstructured":"The WHOQOL Group (1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 28:551\u2013558","journal-title":"Psychol Med"},{"key":"415_CR37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00127-004-0717-9","volume":"39","author":"HY Tan","year":"2004","unstructured":"Tan HY, Choo WC et al (2004) A community study of the health-related quality of life of schizophrenia and general practice outpatients in Singapore. Soc Psychiatry Psychiatr Epidemiol 39:106\u2013112","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"415_CR38","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","volume":"41","author":"The WHOQOL Group","year":"1995","unstructured":"The WHOQOL Group (1995) The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 41:1403\u20131409","journal-title":"Soc Sci Med"},{"key":"415_CR39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.172.1.11","volume":"172","author":"J Wing","year":"1998","unstructured":"Wing J et al (1998) Health of the Nation Outcome Scales (HoNOS): Research and development. Br J Psychiatry 172:11\u201318","journal-title":"Br J Psychiatry"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-008-0415-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00127-008-0415-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-008-0415-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T08:04:50Z","timestamp":1558598690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00127-008-0415-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,19]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1007\/s00127-008-0415-0","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,19]]}}}